Trademark Logo
Application Number:4457250
Status: DRAFT
Class:5
Applicant:SCYNEXIS, INC.
Filing Date:Fri, 28 Feb 2020
In Progress

Is this your trademark application?

"IBREXGYNPriority claimed from 28/08/2019; Application No. : 88597137 ;United States of America" is still moving through the registration pipeline. Most applications hit at least one hurdle — objection, opposition or a hearing — and deadlines at each stage are short. Get notified the moment the status changes.

Get free status guidance

+91

Trademark Information

TrademarkIBREXGYNPriority claimed from 28/08/2019; Application No. : 88597137 ;United States of America
Trademark TypeWordmark
Class5
Application Number4457250
Nature/Scope of businessPharmaceutical preparations for fungal infections; pharmaceutical preparations for the treatment of infections; anti- infectives; anti-fungal pharmaceuticals; therapeutic preparations, namely, glucan synthase inhibitors
PublicationIn Journal No. 1948
Status DRAFT
Applicant:SCYNEXIS, INC.
Applicant Address1 Evertrust Plaza, 13th Floor, Jersey City, NEW JERSEY 07302, United States of America A Delaware Corporation
JurisdictionDELHI
AgentLALL & SETHI
Agent AddressD-17, South Extension Part II, New Delhi 110049, India

Frequently Asked Questions

What is the status of trademark IBREXGYNPriority claimed from 28/08/2019; Application No. : 88597137 ;United States of America?
The trademark application number 4457250 is currently marked as "DRAFT" in the official trademark registry.
Who is the owner of trademark IBREXGYNPriority claimed from 28/08/2019; Application No. : 88597137 ;United States of America?
The trademark application number 4457250 is owned by SCYNEXIS, INC..
Which class does trademark IBREXGYNPriority claimed from 28/08/2019; Application No. : 88597137 ;United States of America belong to?
Trademark application number 4457250 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 4457250?
The trademark agent associated with application number 4457250 is LALL & SETHI.
Was trademark IBREXGYNPriority claimed from 28/08/2019; Application No. : 88597137 ;United States of America published in the journal?
Yes, trademark application number 4457250 was published in Journal No. 1948.
What is trademark IBREXGYNPriority claimed from 28/08/2019; Application No. : 88597137 ;United States of America?
Trademark application number 4457250 relates to "Pharmaceutical preparations for fungal infections; pharmaceutical preparations for the treatment of infections; anti- infectives; anti-fungal pharmaceuticals; therapeutic preparations, namely, glucan synthase inhibitors".

File Trademark at Just ₹1,499 + Govt Fees

Get your trademark registered with expert guidance. Limited time offer!

File Now
Expert Consultation
Quick Processing
100% Support
Free Report

Get Detailed Trademark Report

Comprehensive analysis of your trademark search delivered to your phone

+91

What you'll get:

  • Complete trademark analysis
  • Conflict assessment
  • Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified